Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups

Por Gomez-Bougie, Patricia, Halliez, Maxime, Maïga, Sophie, Godon, Catherine, Kervoëlen, Charlotte, Pellat-Deceunynck, Catherine, Moreau, Philippe, Amiot, Martine
Publicado no Cancer Biol Ther (2014)

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma

Por Chiron, David, Dousset, Christelle, Brosseau, Carole, Touzeau, Cyrille, Maïga, Sophie, Moreau, Philippe, Pellat-Deceunynck, Catherine, Le Gouill, Steven, Amiot, Martine
Publicado no Oncotarget (2015)

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

Por Moreaux, Jérôme, Klein, Bernard, Bataille, Régis, Descamps, Géraldine, Maïga, Sophie, Hose, Dirk, Goldschmidt, Hartmut, Jauch, Anna, Rème, Thierry, Jourdan, Michel, Amiot, Martine, Pellat-Deceunynck, Catherine
Publicado em 2011

Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors

Por Sarr, Jean Biram, Remoue, Franck, Samb, Badara, Dia, Ibrahima, Guindo, Sohibou, Sow, Cheikh, Maiga, Sophie, Tine, Seydou, Thiam, Cheikh, Schacht, Anne-Marie, Simondon, François, Konate, Lassana, Riveau, Gilles
Publicado em 2007

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells

Por Gillardin, Pierre-Samuel, Descamps, Géraldine, Maiga, Sophie, Tessoulin, Benoit, Djamai, Hanane, Lucani, Benedetta, Chiron, David, Moreau, Philippe, Le Gouill, Steven, Amiot, Martine, Pellat-Deceunynck, Catherine, Moreau-Aubry, Agnès
Publicado no Int J Mol Sci (2017)

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53(abnormal) myeloma cells independently of the p53 pathway

Por Surget, Sylvanie, Descamps, Géraldine, Brosseau, Carole, Normant, Vincent, Maïga, Sophie, Gomez-Bougie, Patricia, Gouy-Colin, Nadège, Godon, Catherine, Béné, Marie C, Moreau, Philippe, Le Gouill, Steven, Amiot, Martine, Pellat-Deceunynck, Catherine
Publicado em 2014

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

Por Storti, Paola, Toscani, Denise, Airoldi, Irma, Marchica, Valentina, Maiga, Sophie, Bolzoni, Marina, Fiorini, Elena, Campanini, Nicoletta, Martella, Eugenia, Mancini, Cristina, Guasco, Daniela, Ferri, Valentina, Donofrio, Gaetano, Aversa, Franco, Amiot, Martine, Giuliani, Nicola
Publicado no Haematologica (2016)

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Por Casara, Patrick, Davidson, James, Claperon, Audrey, Le Toumelin-Braizat, Gaëtane, Vogler, Meike, Bruno, Alain, Chanrion, Maïa, Lysiak-Auvity, Gaëlle, Le Diguarher, Thierry, Starck, Jérôme-Benoît, Chen, Ijen, Whitehead, Neil, Graham, Christopher, Matassova, Natalia, Dokurno, Pawel, Pedder, Christopher, Wang, Youzhen, Qiu, Shumei, Girard, Anne-Marie, Schneider, Emilie, Gravé, Fabienne, Studeny, Aurélie, Guasconi, Ghislaine, Rocchetti, Francesca, Maïga, Sophie, Henlin, Jean-Michel, Colland, Frédéric, Kraus-Berthier, Laurence, Le Gouill, Steven, Dyer, Martin J.S., Hubbard, Roderick, Wood, Mike, Amiot, Martine, Cohen, Gerald M, Hickman, John A., Morris, Erick, Murray, James, Geneste, Olivier
Publicado no Oncotarget (2018)